STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
Dagmar Gotthardt(University of Veterinary Medicine Vienna), Veronika Sexl(University of Veterinary Medicine Vienna), Abbarna A. Cumaraswamy(SGS (Canada)), Richard Moriggl(University of Salzburg), Birgit Strobl(University of Veterinary Medicine Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Christian Stockmann(ZHAW Zurich University of Applied Sciences), Patrick T. Gunning(University of Toronto), Gerwin Heller(Medical University of Vienna), Agnieszka Witalisz‐Siepracka(University of Veterinary Medicine Vienna), Petra Kudweis(University of Veterinary Medicine Vienna), Michaela Prchal‐Murphy(University of Veterinary Medicine Vienna), Elisabeth Straka(University of Veterinary Medicine Vienna), Eva Grundschober(University of Veterinary Medicine Vienna), Eva Maria Putz(University of Veterinary Medicine Vienna), Mathias Müller(University of Veterinary Medicine Vienna)
Cited by 151
Related Papers
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways.
|The EMBO Journal|1993|415
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
|Nature Immunology|2003|363